Home›Companies›Biotech & Pharma›Enveda Therapeutics

Enveda Therapeutics, Inc.

Updated Oct 27, 2026·Latest SEC filing Mar 7, 2023·Suggest an edit

About Enveda Therapeutics

Enveda Therapeutics is a private company based in Boulder, Colorado, incorporated in 2019 in Delaware. It has reported $67,459,759 raised in two offerings on Form D since August 2020. Its chief executive is Viswa Colluru.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 25, 2022Mar 7, 2023$62,459,761fully sold26$2.4MEquityRule 506(b)Form D ↗
Aug 11, 2020Aug 24, 2020$4,999,998fully sold10$499KEquityRule 506(b)Form D ↗
Total, two offerings$67,459,759

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Enveda Therapeutics's Form D filed Mar 7, 2023.

RS
Rohit Sharma
Director
ZD
Zavain Dar
Director
BB
Bruce Beutel
Director
DW
Daniel Wee
Executive officer
SV
VC
Viswa Colluru
Chief Executive Officer and director

Sources

  1. SECEnveda Therapeutics, Inc. filing history